OPCH vs PODD: fair value comparison
Option Care Health, Inc. and Insulet Corporation · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, PODD currently sits closer to the top of our discount ranking. PODD carries the stronger quality grade.
| OPCH | PODD | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $23.70 | $145.13 |
| 12-month range | $20.03–$34.61 | $148.13–$344.92 |
| Sector rank | #8 of 113 Healthcare | #4 of 113 Healthcare |
| Quality grade | C | A |
| Leverage | Low | Moderate |
| Margin trend | Contracting | Expanding |
| Revenue growth | Strong | High |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Downtrend |
| DCF cross-check | Fairly Valued | Overvalued |
| 52-week position | The lower-middle quarter | The bottom quarter |
Full single-stock breakdowns: OPCH fair value analysis · PODD fair value analysis